NCT07103057Terminated
VIZ ACCESS HCM - Multi-Site Registry
ACCESS HCM: Real World Evidence for Artificial-Intelligence-assisted Screening and Access to Care for HCM - A Multi-Site Registry
Source: ClinicalTrials.gov · Last updated 23 Sept 2026
Reason given: Sponsor company opted to shift design into single center investigator initiated study focus.
Brief summary (registry, in English)
To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.
- Status (registry)
- Terminated
- Study type
- Observational
- Enrollment
- 17 (actual)
- First submitted
- 13 May 2025
- Start date
- 13 Jun 2025
- Primary completion date
- 17 Sept 2026
- Lead sponsor
- Viz.ai, Inc.
- Diseases
- Hypertrophic cardiomyopathy
- NCT number
- NCT07103057
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- All Cohorts
- Patients aged 18+ years at time of arrival to healthcare facility
- Patients with a resting 12-lead digital electrocardiogram (ECG) that is flagged by Viz HCM for HCM suspicion
- Additional cohort-specific criteria:
- Cohort 1 - Newly Diagnosed Patients
- Patients have been diagnosed with HCM after the Viz HCM implementation
- Written informed consent is obtained prior to data collection
- Cohort 2 - Previously Diagnosed Patients ● Prior diagnosis of HCM as evidenced by clinical diagnosis documentation prior to Viz HCM implementation
- Cohort 3 - Suspected and Not Diagnosed Patients
- ● Patients did not receive sufficient clinical workup for HCM diagnosis confirmation
- Cohort 4 - Unlikely HCM ● Patient ECG moved to 'Unlikely HCM' group within Viz by site study staff following HCM alert review
- Cohort 5 - Alerts Not Reviewed
- ● HCM alert not reviewed by site study staff during study enrollment period
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Emory University | Atlanta | United States | Unknown status |
| North Shore University Health System | Evanston | United States | Unknown status |
| Thomas Jefferson University | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.